Understanding the use of real-world evidence in health technology reassessments: an interview with Ashley Jaksa, Aetion and Melinda Hanisch, Merck Sharp & Dohme
The Evidence Base
Register with The Evidence Base for free to access this content
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.